Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne Treatment

31 augusti 2012 uppdaterad av: Home Skinovations Ltd.

Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for the Treatment of Mild to Moderate Inflammatory Acne.

This is a clinical research study to determine the ability of the Clear device to treat mild to moderate inflammatory acne, and to determine if the average person is able to use the device properly according to the labeling as describe in the operator manual.

The study involve treatments twice a week over 4 weeks total of 8 treatment sessions, in which the subjects will be treating themselves with the Clear device, and 2 follow-up visits to evaluate the results. The clinical result will be assessed by the investigator for improvement in the acne condition. Treatment will be performed on the face of subjects enrolled and who meet the inclusion criteria.

Studieöversikt

Status

Avslutad

Betingelser

Intervention / Behandling

Detaljerad beskrivning

The subjects will be recruited if they are eligible to participate in the study according with the device labeling presented at the doctor's office by printed ads. Subjects will be given information about the Clear device according to its labeling. After reading the information and labeling, it will be the subjects' decision if they understand the device label information and if they want to participate in the study. The investigator will review the inclusion / exclusion criteria with the subjects to ensure eligibility.

Studietyp

Interventionell

Inskrivning (Faktisk)

50

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

  • Kanada
    • Ontario
      • Toronto, Ontario, Kanada, M5R3N8
        • SpaMedica

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

21 år till 65 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  1. Presence of mild to moderate acne.
  2. Skin Type I to VI (Fitzpatrick).
  3. Males or females who are 21-65 years old.
  4. Willingness to follow the treatment schedule, post-treatment care and have photographs taken.

Exclusion Criteria:

  1. Pacemaker or internal defibrillator.
  2. Permanent implant in the treated area, such as metal plates and screws or silicon, unless deep enough in the bone.
  3. Skin areas that have been injected with Botox/ Hyaluronic acid /collagen/fat injections or other augmentation methods with bio-material during last 6 months.
  4. Current or history of skin cancer, or any other type of cancer, or pre-malignant moles.
  5. Current severe medical conditions, such as heart and lung disorders.
  6. Pregnant or breastfeeding.
  7. Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications.
  8. History of diseases stimulated by heat, such as recurrent Herpes Simplex (cold sores) in the treatment area, unless treated by following a preventive regime.
  9. Poorly controlled endocrine disorders, such as diabetes or thyroid disorders.
  10. Any active skin condition in the treatment area, such as sores, psoriasis, eczema, and rash and rosacea.
  11. History of skin disorders, keloids (excessive scarring), abnormal wound healing, as well as very dry and fragile skin.
  12. History of bleeding disorders, or use of anticoagulants in the last 10 days.
  13. Any facial surgery performed within 12 months prior to treatment.
  14. Facial dermabrasion, facial resurfacing, or deep chemical peeling within the last 3 months.
  15. Received treatment with light, laser, radiofrequency (RF), or other devices in the treated area within 6 months.
  16. Used isotretinoin (Accutane®) within 6 months prior to treatment.
  17. Using of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-containing agents) 1 week before and after each treatment session.
  18. Subjects that are currently or have recently been treated with Alpha-Hydroxi Acids (AHAs), Beta-Hydroxi Acids (BHAs), Retin-A®, topical retinoids or azelaic acid.
  19. Subjects that have been on a steroid regimen within the past 3 months.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: lession count reduction post treatment
  • A total of 50 subjects were included.
  • The majority are female (62 %)
  • At baseline the average number of lesions was 20.5±7.1, ranging from 6 to 36 lesions.
  • All subjects demonstrated a reduction in lesion count.
  • The average improvement after one month was 56.7%±8.9%, and remained similar also after 3 months 57.7%±9.4%.
  • The percent of responders (with at least 40% of reduction) was 94% after 1 month and 96% after 3 months
  • The Percent of responders is similar for males & females and similar for cheeks & front.
Enhet: light based device for treatment of acne

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Acne lession count
Tidsram: 3 months post treatment
acne count post treatment compared to based line count
3 months post treatment

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Home Skinovations Ltd.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 november 2011

Primärt slutförande (Faktisk)

1 april 2012

Avslutad studie (Faktisk)

1 april 2012

Studieregistreringsdatum

Först inskickad

31 augusti 2012

Först inskickad som uppfyllde QC-kriterierna

31 augusti 2012

Första postat (Uppskatta)

5 september 2012

Uppdateringar av studier

Senaste uppdatering publicerad (Uppskatta)

5 september 2012

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

31 augusti 2012

Senast verifierad

1 augusti 2012

Mer information

Termer relaterade till denna studie

Nyckelord

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • C1

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera